Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by consultant99on Sep 14, 2019 12:03pm
121 Views
Post# 30126905

RE:RE:Warrants

RE:RE:WarrantsI don’t disagree with your points. I bought the warrants because I believe the share price will eventually trade into double digits within the lifespan of the warrants and I wanted maximum upside exposure to get the most bang fir my buck.

You are quite correct that at $5 the warrants would trade at about $4.65 which would be their intrinsic value equal to the share price - the strike price of 0.35 

Currently the warrants have no intrinsic value and the 0.16 represents time value of the warrants.

I fully expect the shares to start outperforming the warrants as the share price gets to and exceeds the 0.35 strike price. Currently the warrants trade at an 0.08 discount to the shares and that at some higher price the discount will max out at 0.35; typically with options the time value starts to fall when the share price starts to rise above the strike price. So any further narrowing of the discount would allow for an attractive conversion back into shares to catch their eventual outperformance




Bullboard Posts